全球球囊瓣环成形装置市场规模、份额、趋势和成长分析报告（2026-2034年）

预计球囊瓣环成形装置市场将从 2025 年的 32.5 亿美元成长到 2034 年的 51.3 亿美元，2026 年至 2034 年的复合年增长率为 5.19%。

由于主动脉瓣狭窄和二尖瓣狭窄等心臟瓣膜疾病的盛行率不断上升，全球球囊瓣环成形器械市场正经历显着增长。球囊瓣环成形是一种微创外科手术，可透过扩张狭窄的心臟瓣膜来改善血流。微创技术在心臟治疗领域的日益普及也推动了该市场的成长。

心血管疾病发生率的上升以及易患心臟瓣膜疾病的老年人口不断增加，推动了这个市场的发展。导管介入器械和影像技术的进步正在提高球囊瓣环成形的安全性和有效性。

随着介入性心臟病学技术的进步，市场预计将持续成长。更精准、更耐用的球囊导管系统的研发将有助于改善治疗效果。随着医疗机构越来越多地选择微创心臟治疗，球囊瓣环成形装置的市场预计将稳定扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球球囊瓣环成形装置市场：依产品类型划分

• 市场分析、洞察与预测
• 标准气球
• 切割球囊
• 球囊导管
• 高压气球
• 低压气球

第五章：全球球囊瓣环成形装置市场：依应用划分

• 市场分析、洞察与预测
• 主动脉瓣狭窄
• 肺动脉瓣狭窄

第六章：全球球囊瓣环成形装置市场：依年龄组别划分

• 市场分析、洞察与预测
• 儿童
• 成人

第七章 全球球囊瓣环成形装置市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 门诊手术中心
• 专科诊所
• 其他最终用户

第八章 全球球囊瓣环成形装置市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton
  • Dickinson And Company
  • Boston Scientific Corporation
  • Cardinal Health Inc
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • Innomed Medical Development Ltd
  • JOTEC GmbH
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • NuMED Canada Inc
  • NuMED Inc
  • Osypka Medical GmbH
  • Teleflex Incorporated

The Balloon Valvuloplasty Devices Market size is expected to reach USD 5.13 Billion in 2034 from USD 3.25 Billion (2025) growing at a CAGR of 5.19% during 2026-2034.

The Global Balloon Valvuloplasty Devices Market is witnessing significant growth due to the increasing prevalence of heart valve disorders such as aortic stenosis and mitral valve stenosis. Balloon valvuloplasty is a minimally invasive procedure used to widen narrowed heart valves and improve blood flow. The growing adoption of less invasive cardiac treatments has supported the expansion of this market.

The market is driven by the rising incidence of cardiovascular diseases and the growing aging population, which is more susceptible to heart valve conditions. Technological advancements in catheter-based devices and imaging techniques have improved the safety and effectiveness of balloon valvuloplasty procedures.

In the future, the market is expected to grow with continued advancements in interventional cardiology technologies. The development of more precise and durable balloon catheter systems will enhance procedural outcomes. As healthcare providers increasingly prefer minimally invasive cardiac treatments, the balloon valvuloplasty devices market is anticipated to expand steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Standard Balloon
• Cutting Balloon
• Scoring Balloon
• High-pressure Balloon
• Low-pressure Balloon

By Application

• Aortic Valve Stenosis
• Pulmonary Valve Stenosis

By Age Group

• Pediatric
• Adult

By End Use

• Hospitals
• Ambulatory Surgical Centres
• Specialty Clinics
• Other End Users

COMPANIES PROFILED

• Abbott Laboratories, B Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health Inc, Cook Medical LLC, Edwards Lifesciences Corporation, Innomed Medical Development Ltd, JOTEC GmbH, Medtronic plc, MicroPort Scientific Corporation, NuMED Canada Inc, NuMED Inc, Osypka Medical GmbH, Teleflex Incorporated
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Standard Balloon Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cutting Balloon Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Scoring Balloon Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. High-pressure Balloon Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Low-pressure Balloon Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Aortic Valve Stenosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pulmonary Valve Stenosis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET: BY AGE GROUP 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Age Group
• 6.2. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centres Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Application
  • 8.2.3 By Age Group
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Application
  • 8.3.3 By Age Group
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Application
  • 8.4.3 By Age Group
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Application
  • 8.5.3 By Age Group
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Application
  • 8.6.3 By Age Group
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BALLOON VALVULOPLASTY DEVICES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Abbott Laboratories
  • 10.2.2 B. Braun Melsungen AG
  • 10.2.3 Becton
  • 10.2.4 Dickinson And Company
  • 10.2.5 Boston Scientific Corporation
  • 10.2.6 Cardinal Health Inc
  • 10.2.7 Cook Medical LLC
  • 10.2.8 Edwards Lifesciences Corporation
  • 10.2.9 Innomed Medical Development Ltd
  • 10.2.10 JOTEC GmbH
  • 10.2.11 Medtronic Plc
  • 10.2.12 MicroPort Scientific Corporation
  • 10.2.13 NuMED Canada Inc
  • 10.2.14 NuMED Inc
  • 10.2.15 Osypka Medical GmbH
  • 10.2.16 Teleflex Incorporated